Search Results - "DuPont, R L"

Impairment in Pure and Comorbid Generalized Anxiety Disorder and Major Depression at 12 Months in Two National Surveys by Kessler, Ronald C., DuPont, Robert L., Berglund, Patricia, Wittchen, Hans-Ulrich

“…OBJECTIVE: Generalized anxiety disorder might be better conceptualized as a prodrome, residual, or severity marker of major depression or other comorbid…”
Get full text

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder by DAVIDSON, J. R. T, DUPONT, R. L, HEDGES, D, HASKINS, J. T

“…The objective of this randomized, double-blind study was to compare the efficacy and safety of venlafaxine extended release (XR) and buspirone in outpatients…”
Get full text

Twelve-step and mutual-help programs for addictive disorders by Chappel, J N, DuPont, R L

“…Psychiatrists may wonder why both addiction treatment and the 12-step programs recommend abstinence. In his 50-year follow-up of two groups of alcoholics,…”
Get more information

Drug testing by urine and hair analysis: complementary features and scientific issues by DuPont, Robert L., Baumgartner, Werner A.

“…Hair analysis and urinalysis are complementary tests for establishing drug use. Hair analysis provides long-term information, from months to years, concerning…”
Get full text

Drug legalization, harm reduction, and drug policy by DUPONT, R. L, VOTH, E. A

“…The current U.S. policy options on drug use are reviewed in the context of the history of drug policy in the United States. A restrictive drug policy is a…”
Get full text

The Origins of the Minnesota Model of Addiction Treatment-A First Person Account by Anderson, Daniel J., McGovern, John P., Dupont, Robert L.

“…The Minnesota Model, also known as the abstinence model, of addiction treatment was created in a state mental hospital in the 1950s by two young men, one who…”
Get full text

Biology and the Environment-Rethinking Demand Reduction by Dupont, Robert L.

“…In a speech to the American Society of Addiction Medicine upon receipt of the second annual John P. McGovern Award, DuPont discusses what society and addiction…”
Get full text

The war on drugs by DuPont, R L

Get full text

Addiction: a new paradigm by DuPont, R L

“…The older view of addiction was that people became addicted because they were ignorant of the risks of addiction, they were unhappy, or they lacked healthy…”
Get more information

Alprazolam and benzodiazepine dependence by SELLERS, E. M, CIRAULO, D. A, BARBEE, DUPONT, R. L, GRIFFITHS, R. R, KOSTEN, T. R, ROMACH, M. K, WOODY, G. E, SHADER, GREENBLATT, BALLENGER

“…The incidence of nonmedical use of alprazolam is very low relative to its widespread legitimate medical use; in fact, given the millions of patients who have…”
Get full text

Thinking about stopping treatment for panic disorder by DUPONT, R. L

“…The lifelong nature of panic disorder and the development of effective new treatments have focused attention on long-term use of antipanic medications,…”
Get full text

Examining the debate on the use of medical marijuana by DuPont, R L

“…The opium poppy and the coca leaf offer useful perspectives on the current controversies over medical marijuana. In both cases, purified synthetic analogues of…”
Get more information

Anxiety and addiction: a clinical perspective on comorbidity by DuPont, R L

“…Substance use disorders and the anxiety disorders, the two most prevalent mental disorders in the United States, are often comorbid, undiagnosed, and poorly…”
Get more information

Medicinal Marijuana? by DuPont, Robert L, Kanof, Philip D, Hensel, William A, Domino, Laurence, Dorizzi, Romolo M, Taub, Arthur, Deutsch, Marshall E, Grant, David, Copple, James E, Tilelli, John A, Johnson, Gary Allen, Mays, Richard, Tashkin, Donald P, Roth, Michael D, Dubinett, Steven M, Kassirer, Jerome P

“…To the Editor: With respect to your editorial on the medicinal use of marijuana (Jan. 30 issue), 1 I made it a priority, as the first director of the National…”
Get full text

Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States by McLellan, A Thomas, Skipper, Gregory S, Campbell, Michael, DuPont, Robert L

“…Objective To evaluate the effectiveness of US state physician health programmes in treating physicians with substance use disorders.Design Five year,…”
Get full text

Medicines and drug testing in the workplace by DuPont, R L

“…Drug testing at work is rapidly becoming the standard in the United States. For drug testing to fulfill its promise as a vital part of the effort to end the…”
Get more information

Prevention of adolescent chemical dependency by DuPont, R L

“…Chemical dependency is part of a significant pattern of serious health problems resulting from the breakdown of social control over impulsive, pleasure-driven…”
Get more information

Discontinuation of alprazolam after long-term treatment of panic-related disorders by DuPont, R L, Swinson, R P, Ballenger, J C, Burrows, G D, Noyes, R, Rubin, R T, Rifkin, A, Pecknold, J C

“…Discontinuation of alprazolam after long-term treatment of 142 patients with panic-related disorders was examined in five study sites using a telephone…”
Get more information

Responsible prescribing of controlled substances by Voth, E A, Dupont, R L, Voth, H M

“…One-third of the disciplinary actions against physicians in 1990 involved prescriptions for controlled or abusable drugs. Problems involving the prescribing of…”
Get more information

A physician's guide to discontinuing benzodiazepine therapy by DuPont, R L

“…Practicing physicians need to have practical techniques to help patients who want to stop using benzodiazepines. I have developed three approaches that usually…”
Get full text